Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2002
10/08/2002US6462053 Neuropeptide y receptor antagonists; cardiovascular and central nervous system disorders and metabolic diseases; hypertension, nephropathy, heart disease, vasospasm, arteriosclerosis
10/08/2002US6462046 Non-thiazolidinedione ppargamma agonists; useful in modulation of blood glucose and the increase of insulin sensitivity in mammals
10/08/2002US6462043 Method for producing substituted-2-nitroguanidine derivatives
10/08/2002US6462037 Such as 7-chloro-3-methyl-5-(2-cyclopropylethynyl)-1,5-dihydro-5-(trifluoromethyl) -1,4-benzodiazepin-2-one; protease inhibitors
10/08/2002US6462036 Inhibiting signal transduction by modulating activity of receptor and nonreceptor tyrosine and serine/threonine kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism
10/08/2002US6462032 Cyclic regimens utilizing indoline derivatives
10/08/2002CA2066083C Benzodiazepine analogs as cholecystokinin antagonists
10/06/2002WO2003088897A2 Fab i inhibitors
10/06/2002CA2444597A1 Fab i inhibitors
10/03/2002WO2002076979A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002WO2002076977A2 Rho-kinase inhibitors
10/03/2002WO2002076976A2 Rho-kinase inhibitors
10/03/2002WO2002076975A1 Chemical derivatives and their use as anti-telomerase agent
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076953A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
10/03/2002WO2002076951A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
10/03/2002WO2002076950A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
10/03/2002WO2002076947A1 Mch antagonists and their use in the treatment of obesity
10/03/2002WO2002076945A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002WO2002076472A2 Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
10/03/2002WO2002076459A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
10/03/2002WO2002076438A2 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
10/03/2002WO2002076404A2 Fatty alcohol drug conjugates
10/03/2002WO2002076402A2 Fatty amine drug conjugates
10/03/2002WO2002057248A3 Inhibitors of cruzipain and other cysteine proteases
10/03/2002WO2001019800A9 Mediators of hedgehog signaling pathways, compositions and uses related thereto
10/03/2002WO2000034265A3 Quinoline-indole antimicrobial agents
10/03/2002US20020143194 Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers
10/03/2002US20020143043 For therapy and prophylaxis of rheumatoid arthritis, or of allergic disorders, asthma, inflammation; inhibitors of the adhesion and migration of leucocytes and/or antagonists of adhesion receptor VLA-4 belonging to the integrins group
10/03/2002US20020143026 Induce mitotic arrest thereby making them useful as anti-cancer agents; also for therapy of diseases which can be treated by inducing mitotic arrest
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020143017 Pyridazinone aldose reductase inhibitors
10/03/2002US20020143014 Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
10/03/2002US20020143011 Tri-substituted phenyl derivatives and processes for their preparation
10/03/2002US20020143007 Donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase; for use in therapy
10/03/2002US20020142023 Insecticide, miticide
10/03/2002CA2442012A1 Chemical derivatives and their use as anti-telomerase agent
10/03/2002CA2441790A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002CA2441568A1 Pharmaceutical combinations for the treatment of cancer
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002CA2440389A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002CA2439676A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/02/2002EP1245231A2 Pharmaceutical formulations containing darifenacin
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1244653A1 Non peptide tachykinin receptor antagonists
10/02/2002EP1244652A1 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
10/02/2002EP1244651A1 Diamidine compounds as dna minor groove binders
10/02/2002EP1244646A1 Dinitrile intermediates for the synthesis of omapatrilat and methods for producing same
10/02/2002EP1244639A1 2-cyclohexyl benzimidazole nmda/nr2b antagonists
10/02/2002EP1244631A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
10/02/2002EP1244629A2 Quinolone compounds for use in treating viral infections
10/02/2002EP1244628A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/02/2002EP1244627A1 Picolinic acid derivatives and their use as fungicides
10/02/2002EP1244621A1 Nitrile derivatives as cathepsin k inhibitors
10/02/2002EP1244617A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
10/02/2002EP1244446A1 Thrombopoietin mimetics
10/02/2002EP1047684B1 Substituted alpha,beta-anellated butyrolactones
10/02/2002EP0989851B1 Self-emulsifying formulation for acidic lipophilic compounds
10/02/2002EP0906279B1 Pyrrole derivatives
10/02/2002EP0706521B1 Imides as tnf alpha inhibitors
10/02/2002EP0689534B1 Amide derivatives as 5-ht 1a? ligands
10/02/2002DE10115945A1 Substituierte 2-Carba-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/02/2002DE10113587A1 Verfahren zur Herstellung von substituierten Pyrrolen A process for the preparation of substituted pyrroles
10/02/2002DE10111862A1 Neue Diaminopyrazol-Derivate und diese Verbindungen enthaltende Färbemittel New diaminopyrazole derivatives and compounds containing colorants
10/02/2002CN1372556A Heterocyclic compound inhibiting angiogenesis
10/02/2002CN1372552A Pyrimidine derivatives and herbicides containing the same
10/02/2002CN1372551A Process for preparing 1-substituted 5-hydroxymethyl imidazole
10/02/2002CN1372549A Fungicidies
10/02/2002CN1372546A Fused pyrrolecarboxamides GABA brain receptor ligands
10/02/2002CN1372545A 吲哚衍生物 Indole derivatives
10/02/2002CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
10/02/2002CN1091594C Use of anti-viral compound in preparing medicine for curing virus infection
10/01/2002US6458951 For treatment of male erectile dysfunction, female sexual dysfunction
10/01/2002US6458830 The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis and postherpetic neuralgia.
10/01/2002US6458814 Vitronectin receptor antagonists and are useful in the treatment of osteoporosis: treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor,
10/01/2002US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer
10/01/2002US6458812 Muscarinic antagonists
10/01/2002US6458810 Pharmaceutically active isoindoline derivatives
10/01/2002US6458807 Methods for treating vascular dementia
10/01/2002US6458801 Benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same
10/01/2002US6458798 Bicyclic pyrimidine compounds and therapeutic use thereof
10/01/2002US6458788 4-hydroxycinnoline-3-carboxyamides as antiviral agents
10/01/2002US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002US6458768 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
10/01/2002US6458474 Methine compound, material for organic luminescence element, organic luminescence element using the same
10/01/2002CA2272719C Apo b-secretion/mtp inhibitory amides
10/01/2002CA2228370C Piperazino derivatives as neurokinin antagonists
10/01/2002CA2059708C Indole derivatives
10/01/2002CA2050993C Intermediates to 1-carbacephalosporins and process for preparation thereof
09/2002
09/30/2002CA2379791A1 Novel triazine compounds useful as sorbitol dehydrogenase inhibitors
09/26/2002WO2002074768A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
09/26/2002WO2002074767A1 Metalloproteinase inhibitors
09/26/2002WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
09/26/2002WO2002074757A1 Method for producing substituted pyrroles and furans
09/26/2002WO2002074754A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
09/26/2002WO2002074752A1 Metalloproteinase inhibitors
09/26/2002WO2002074751A1 Metalloproteinase inhibitors
1 ... 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 ... 694